Prothena Corporation plc

(NASDAQ:PRTA)

Latest On Prothena Corporation plc (PRTA):

Date/Time Type Description Signal Details
2023-05-17 21:06 ESTNewsProthena adds former FDA neuro chief Billy Dunn to director boardN/A
2023-05-12 13:28 ESTNewsCORPORATE OVERVIEWN/A
2023-05-07 10:56 ESTNewsProthena Biosciences' Unique Approach To Protein Misfolding Could Be The FutureN/A
2023-04-13 09:43 ESTNewsWalgreens, Prothena in pact for early-stage Alzheimer’s trialN/A
2023-02-24 07:45 ESTNewsProthena Corporation plc (PRTA) Q4 2022 Earnings Call TranscriptN/A
2023-02-24 07:45 ESTNewsProthena Corporation plc 2022 Q4 - Results - Earnings Call PresentationN/A
2023-02-23 18:41 ESTNewsProthena GAAP EPS of $0.12 beats by $0.61, revenue of $49.9M beats by $20.76MN/A
2023-02-08 11:34 ESTNewsProthena: I'm Not A Buyer At A $3 Billion ValuationN/A
2023-01-31 19:19 ESTNewsProthena says Alzheimer’s candidate was safe in early-stage trialN/A
2023-01-27 12:21 ESTNewsProthena initiated at overweight at Piper Sandler on antibody platform, pipelineN/A
2023-01-17 23:22 ESTNewsProthena: 3 Alzheimer's Catalysts Will Likely Define Share Price Performance In 2023N/A
2022-12-15 14:38 ESTNewsProthena prices 3.25M shares public offeringN/A
2022-12-14 04:10 ESTNewsProthena falls over 6% after hours on proposed stock offeringN/A
2022-11-05 00:41 ESTNewsProthena drops 9% as RBC Capital Markets downgrades citing valuationN/A
2022-09-29 14:30 ESTNewsProthena: Paying A Premium To Cover All The Alzheimer's BasesN/A
2022-09-28 23:27 ESTNewsProthena climbs 80% as Bofa upgrades after rivals’ Alzheimer’s dataN/A
2022-08-09 06:51 ESTNewsProthena GAAP EPS of -$0.88 misses by $0.31N/A
2022-08-05 22:42 ESTNewsProthena Q2 2022 Earnings PreviewN/A
2022-05-05 08:14 ESTNewsProthena Q1 2022 Earnings PreviewN/A
2022-04-06 20:06 ESTNewsElectric vehicle stocks are sliding with Shanghai COVID outbreak threatening the supply chainN/A
2022-03-31 16:13 ESTNewsProthena Corporation (PRTA) Investor Presentation - SlideshowN/A
2022-03-29 08:38 ESTNewsProthena's PRX012 for Alzheimer’s gets FDA nod to enter clinical trialN/A
2022-03-16 09:17 ESTNewsProthena plans IND filing for Alzheimer’s candidate in 2023N/A
2022-02-18 00:00 ESTNewsProthena GAAP EPS of -$0.71, revenue of $1.17MN/A
2022-02-18 00:00 ESTNewsProthena Corporation plc (PRTA) CEO Gene Kinney on Q4 2021 Results - Earnings Call TranscriptN/A
2022-01-19 01:38 ESTNewsEV stock roundup: Blink Charging and Hyzon Motors rally while startup names struggleN/A
2021-12-01 07:18 ESTNewsProthena: A Biotech Company With A Promising PipelineN/A
2021-11-05 12:01 ESTNewsProthena EPS misses by $0.15, misses on revenueN/A
2021-10-01 20:00 ESTNewsProthena names Brandon Smith as COON/A
2021-08-06 09:05 ESTNewsProthena EPS misses by $0.30, misses on revenueN/A
2021-07-26 21:14 ESTNewsProthena presents new data from Alzheimer’s portfolio at AAIC 2021N/A
2021-07-24 16:19 ESTNewsProthena: Underrated Player In Alzheimer's And Parkinson's Close To Securing First Drug ApprovalN/A
2021-07-21 20:28 ESTNewsCould Lilly's donanemab, others for Alzheimer's get a boost from Biogen approval?N/A
2021-07-21 20:28 ESTNewsProthena price target raised at Oppenheimer after FDA nod for Biogen’s Alzheimer’s therapyN/A
2021-07-21 20:20 ESTNewsProthena nears a four-year high with a Street high target from JefferiesN/A
2021-07-21 20:18 ESTNewsBiogen’s decision to halt development of anti-tau antibody in Alzheimer’s hurts rivalsN/A
2021-07-21 20:17 ESTNewsCourt decision on ACA is a positive on the sector: Bernstein, Prothena upgraded at BofA; in today’s analyst actionN/A
2021-07-21 20:12 ESTNewsProthena secures $80M from Bristol Myers for US license to PRX005N/A
2021-07-21 20:08 ESTNewsProthena: Well-Positioned In Parkinson's And Alzheimer'sN/A
2021-07-21 19:59 ESTNewsNovo Nordisk inks purchase deal for Prothena’s ATTR amyloidosis programN/A
2021-07-21 19:58 ESTNewsProthena shares lag despite up to $1.2B deal with Novo NordiskN/A
2021-04-19 15:46 ESTNewsProthena's PRX004 shows benefits in neuropathy and cardiac functionN/A
2021-04-06 07:52 ESTNewsProthena names new medical chiefN/A
2021-03-24 23:43 ESTNewsProthena trades lower after pricing public offeringN/A
2021-03-24 04:54 ESTNewsProthena commences offering of common shares; stock down 6% after-hoursN/A
2021-03-16 21:47 ESTAnalyst RatingThe Analyst Target Price has increased from $28.43 to $29.57.Buy
2021-03-01 00:15 ESTAnalyst RatingThe Analyst Target Price has increased from $26.43 to $28.43.Buy
2021-02-27 00:27 ESTNewsPremarket analyst action - healthcareN/A
2021-02-15 00:18 ESTAnalyst RatingThe Analyst Target Price has increased from $24.29 to $26.43.Buy
2021-02-12 23:25 ESTNewsProthena surges as Jefferies sees a 100% upsideN/A

About Prothena Corporation plc (PRTA):

Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing PRX002/RG7935 that is in Phase 2 clinical trial for treating Parkinson's disease and other related synucleinopathies; and PRX004, an antibody that is in Phase 1 clinical trial for the treatment of ATTR amyloidosis. Its discovery-stage programs include Tau for treating Alzheimer's disease, frontotemporal dementia, progressive supranuclear palsy, chronic traumatic encephalopathy, and other tauopathies; Aß, or Amyloid Beta, a protein for the treatment of Alzheimer's disease; TDP-43 for amyotrophic lateral sclerosis and frontotemporal dementia; and other products for neurodegenerative diseases. The company has a license, development, and commercialization agreement with F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. to develop and commercialize antibodies that target alpha-synuclein; and a collaboration agreement with Bristol-Myers Squibb to develop antibodies. Prothena Corporation plc was founded in 2012 and is based in Dublin, Ireland.

PRTA Quotes by TradingView

See Advanced Chart

General

  • Name Prothena Corporation plc
  • Symbol PRTA
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 66
  • Fiscal Year EndDecember
  • IPO Date2012-12-21
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.prothena.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 1078.13
  • Price/Book (Most Recent Quarter) 5.01
  • Enterprise Value Revenue 754.71
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.32
  • Next Year EPS Estimate -$3.64
  • Next Quarter EPS Estimate -$0.44
  • Operating Margin -13216%
  • Return on Assets -19%
  • Return on Equity -49%
  • Revenue 853000
  • Earnings Per Share -$2.10
  • Revenue Per Share $0.02
  • Gross Profit -74031000
  • Quarterly Earnings Growth 40.6%
View More

Highlights

  • Market Capitalization 972.29 million
  • EBITDA -90957000
  • PE Ratio -7.51
  • PEG Ratio 0.8
  • Analyst Target Price $29.57
  • Book Value Per Share $4.61
View More

Share Statistics

  • Shares Outstanding 39.99 million
  • Shares Float 19.65 million
  • % Held by Insiders 5%
  • % Held by Institutions 94.7%
  • Shares Short 979672
  • Shares Short Prior Month 709034
  • Short Ratio 1.45
  • Short % of Float 3%
  • Short % of Shares Outstanding 2%
View More

Technicals

  • Beta 1.63
  • 52 Week High $27.2
  • 52 Week Low $8.32
  • 50 Day Moving Average 19.67
  • 200 Day Moving Average 13.91
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Prothena Corporation plc (PRTA) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Prothena Corporation plc (PRTA) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-11$N/A-$0.77-$0.77-0.18%
2020-09-302020-11-04$N/A-$0.77-$0.65-18.15%
2020-06-302020-08-06$N/A-$0.66-$0.62-7.32%
2020-03-312020-05-06$N/A-$0.59-$0.57-2.98%
2019-12-312020-02-12$256000-$0.54-$0.609.5%
2019-09-302019-11-05$205000-$0.49-$0.514.24%
2019-06-302019-08-06$167000-$0.40-$0.5830.56%
2019-03-312019-05-07$186000-$0.52-$0.6215.68%
2018-12-312019-02-14$194000-$0.56-$0.9541.05%
2018-09-302018-11-06$255000-$0.62-$1.0942.86%
2018-06-302018-08-07$279000-$1.50-$0.97-55.04%
2018-03-312018-05-08$227000-$1.26-$1.281.87%
2017-12-312018-02-14$229000-$1.24-$1.4916.59%
2017-09-302017-11-07$219000-$1.37-$1.413.01%
2017-06-302017-08-08$26.81 million-$0.46-$0.9149.27%
2017-03-312017-05-09$259000-$0.99-$1.3828.02%
2016-12-312017-02-14$171000-$1.41-$1.23-15.1%
2016-09-302016-11-01$286000-$1.26-$1.15-9.23%
2016-06-302016-08-02$333000-$1.18-$0.92-28.57%
2016-03-312016-05-03$265000-$0.81-$0.76-7.11%
2015-12-312016-02-18$307000-$0.76-$0.827.36%
2015-09-302015-11-02$429000-$0.73-$0.66-10.61%
2015-06-302015-08-04$278000-$0.59-$0.56-5.36%
2015-03-312015-05-05$593000-$0.55-$0.596.78%
2014-12-312015-03-05$2.01 million-$0.48-$0.6627.27%
2014-09-302014-11-03$1.49 million-$0.48-$0.6020%
2014-06-302014-08-04$15.12 million$0.06-$0.14142.86%
2014-03-312014-05-05$32.23 million$0.78$0.780%
2013-12-312014-03-06$167000-$0.52-$0.50-4%
2013-09-302013-11-12$171000-$0.55-$0.6616.67%
2013-06-302013-08-12$167000-$0.64-$0.52-23.08%
2013-03-312013-05-29$171000-$0.51
2012-12-312013-03-29$575000-$0.84

Prothena Corporation plc (PRTA) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Prothena Corporation plc (PRTA) Chart:

Prothena Corporation plc (PRTA) News:

Below you will find a list of latest news for Prothena Corporation plc (PRTA) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Prothena Corporation plc (PRTA) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-1712.50CALL0 0219.25TRUE00
2024-05-17150CALL0 0163.19TRUE00
2024-05-1717.50CALL0 0125.22TRUE00
2024-05-17202CALL0 190.75TRUE00
2024-05-1722.50.9CALL15 9779.53FALSE-0.05-0.05
2024-05-17250.38CALL10 8979.69FALSE0.380
2024-05-17300.05CALL9 5779.31FALSE-0.05-0.5
2024-05-17350.05CALL2 210104.75FALSE0.050
2024-05-17400.28CALL0 420FALSE00
2024-05-17450.23CALL0 200FALSE00
2024-05-17500.61CALL0 3970FALSE00
2024-05-1712.50PUT0 00FALSE00
2024-05-17150.19PUT0 100FALSE00
2024-05-1717.50.4PUT158 1478.55FALSE0.40
2024-05-17201.25PUT144 45977.69FALSE00
2024-05-1722.52.7PUT10 11075.43TRUE0.150.06
2024-05-17254.65PUT0 5675.18TRUE00
2024-05-17307.6PUT0 15143.15TRUE00
2024-05-17357.6PUT0 0204.79TRUE00
2024-05-17400PUT0 0245.73TRUE00
2024-05-17450PUT0 0231.85TRUE00
2024-05-17500PUT0 0219.71TRUE00
2024-06-2112.50CALL0 0151.61TRUE00
2024-06-211516.3CALL0 1654.83TRUE00
2024-06-2117.516CALL0 1573.37TRUE00
2024-06-21202.72CALL1 5173.66TRUE2.720
2024-06-2122.51.65CALL1 5075.14FALSE1.650
2024-06-21251.1CALL0 6577.01FALSE00
2024-06-21300.55CALL0 3976.6FALSE00
2024-06-21350.37CALL0 2980.43FALSE00
2024-06-21400.44CALL0 950FALSE00
2024-06-21450.5CALL0 1500FALSE00
2024-06-21500.2CALL0 1570FALSE00
2024-06-21550.5CALL0 170FALSE00
2024-06-21600.2CALL0 660FALSE00
2024-06-21650.35CALL0 200FALSE00
2024-06-21700.13CALL0 900FALSE00
2024-06-21750.05CALL0 450FALSE00
2024-06-2112.50PUT0 00FALSE00
2024-06-21150.38PUT0 4374.33FALSE00
2024-06-2117.50.85PUT0 8875.54FALSE00
2024-06-21201.52PUT0 5777.62FALSE00
2024-06-2122.53.5PUT0 3972.93TRUE00
2024-06-21255.07PUT0 16972.06TRUE00
2024-06-21306.4PUT0 5495.3TRUE00
2024-06-213514.1PUT0 77125.44TRUE00
2024-06-214013.1PUT0 9132.41TRUE00
2024-06-214515.1PUT0 0148.28TRUE00
2024-06-215022.4PUT0 6137.17TRUE00
2024-06-215525.4PUT0 0174.33TRUE00
2024-06-216029.13PUT0 1175.56TRUE00
2024-06-216534.85PUT0 1195.35TRUE00
2024-06-217037.1PUT0 1201.31TRUE00
2024-06-217541.6PUT0 1199.01TRUE00
2024-09-2012.50CALL0 091.52TRUE00
2024-09-20150CALL0 066.05TRUE00
2024-09-2017.50CALL0 073.18TRUE00
2024-09-20204.5CALL0 378.99TRUE00
2024-09-2022.53.9CALL0 278.24FALSE00
2024-09-20254.87CALL0 977.01FALSE00
2024-09-20303CALL0 677.13FALSE00
2024-09-20350.98CALL44 1376.89FALSE0.980
2024-09-20400.6CALL1 776.87FALSE0.60
2024-09-20451.1CALL0 877.01FALSE00
2024-09-20500CALL0 077.87FALSE00
2024-09-2012.50PUT0 079.35FALSE00
2024-09-20151.4PUT0 4278.24FALSE00
2024-09-2017.52.07PUT0 778.81FALSE00
2024-09-20203.5PUT0 978.1FALSE00
2024-09-2022.54.98PUT0 1076.1TRUE00
2024-09-20256.6PUT0 1275.84TRUE00
2024-09-20300PUT0 074.18TRUE00
2024-09-20350PUT0 072.4TRUE00
2024-09-20400PUT0 070.85TRUE00
2024-09-204516.2PUT0 497.24TRUE00
2024-09-20500PUT0 095.82TRUE00
2024-12-2012.50CALL0 099.75TRUE00
2024-12-201510.6CALL0 176.84TRUE00
2024-12-2017.50CALL0 077.34TRUE00
2024-12-20200CALL0 078.21TRUE00
2024-12-2022.50CALL0 079.16FALSE00
2024-12-20250CALL0 078.46FALSE00
2024-12-20307.3CALL0 374.5FALSE00
2024-12-20355.81CALL0 278.22FALSE00
2024-12-20403CALL0 8578.67FALSE00
2024-12-20450CALL0 076.77FALSE00
2024-12-20500.95CALL0 3377.82FALSE00
2024-12-2012.50PUT0 081.3FALSE00
2024-12-20152PUT0 175.28FALSE00
2024-12-2017.52.05PUT0 1378.65FALSE00
2024-12-20200PUT0 077.93FALSE00
2024-12-2022.54.4PUT0 1378.2TRUE00
2024-12-20255.68PUT0 22078.23TRUE00
2024-12-20307.5PUT0 1074.44TRUE00
2024-12-203510.9PUT0 475.22TRUE00
2024-12-204014.3PUT0 474.26TRUE00
2024-12-20450PUT0 075.93TRUE00
2024-12-20500PUT0 085.36TRUE00
2025-01-1712.50CALL0 091.08TRUE00
2025-01-171510.24CALL0 671.94TRUE00
2025-01-1717.50CALL0 085.64TRUE00
2025-01-172013.53CALL0 171.92TRUE00
2025-01-1722.55.69CALL0 2181.81FALSE00
2025-01-17256.6CALL0 3780.99FALSE00
2025-01-17304.7CALL0 2381.06FALSE00
2025-01-17352.6CALL0 1280.32FALSE00
2025-01-17402.26CALL0 15379.78FALSE00
2025-01-17452.45CALL0 32380.33FALSE00
2025-01-17502.8CALL0 578.59FALSE00
2025-01-1712.50PUT0 078.65FALSE00
2025-01-17151.75PUT0 381.95FALSE00
2025-01-1717.53PUT0 7981.83FALSE00
2025-01-17204.7PUT0 4379.76FALSE00
2025-01-1722.50PUT0 079.79TRUE00
2025-01-17256.7PUT0 3179.08TRUE00
2025-01-17309.7PUT0 17677.39TRUE00
2025-01-173515.7PUT0 667.61TRUE00
2025-01-174016.6PUT0 380.03TRUE00
2025-01-17450PUT0 077.75TRUE00
2025-01-17500PUT0 085.36TRUE00
2026-01-1612.50CALL0 060.71TRUE00
2026-01-161518.9CALL0 166.15TRUE00
2026-01-1617.50CALL0 081.29TRUE00
2026-01-16200CALL0 076.97TRUE00
2026-01-1622.50CALL0 074.31FALSE00
2026-01-16250CALL0 072.53FALSE00
2026-01-16307CALL0 1470.43FALSE00
2026-01-16359.05CALL0 169.43FALSE00
2026-01-16404.66CALL0 159.44FALSE00
2026-01-16457.7CALL0 170.19FALSE00
2026-01-16502.75CALL0 1967.81FALSE00
2026-01-1612.52.14PUT0 674.48FALSE00
2026-01-16153.37PUT0 972.79FALSE00
2026-01-1617.54.63PUT0 175.49FALSE00
2026-01-16206.23PUT0 1472.85FALSE00
2026-01-1622.50PUT0 072.4TRUE00
2026-01-16258.9PUT0 073.88TRUE00
2026-01-163012.5PUT0 2571.25TRUE00
2026-01-163516.75PUT0 569.75TRUE00
2026-01-164017.35PUT0 170.21TRUE00
2026-01-16450PUT0 073.3TRUE00
2026-01-16500PUT0 081.11TRUE00

Latest PRTA Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST79$22.78
Jun 13, 2022 7:59 PM EST28$22.78
Jun 13, 2022 7:59 PM EST1$22.74
Jun 13, 2022 7:59 PM EST1$22.74
Jun 13, 2022 7:59 PM EST20$22.78

Prothena Corporation plc (PRTA) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000156761920011041/0001567619-20-011041-index.htm
2018-12-19UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1559053/000000000018038535/0000000000-18-038535-index.htm
2019-04-04UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1559053/000000000019006505/0000000000-19-006505-index.htm
2019-05-29UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1559053/000000000019009087/0000000000-19-009087-index.htm
2019-05-29UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1559053/000000000019009088/0000000000-19-009088-index.htm
2019-07-31UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1559053/000000000019011872/0000000000-19-011872-index.htm
2019-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1559053/000021545719004999/0000215457-19-004999-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1559053/000031506619001267/0000315066-19-001267-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1559053/000031506620001163/0000315066-20-001163-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1559053/000083423720005908/0000834237-20-005908-index.htm
2019-01-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1559053/000089109219000538/0000891092-19-000538-index.htm
2019-03-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1559053/000089109219002760/0000891092-19-002760-index.htm
2018-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000089924318017928/0000899243-18-017928-index.htm
2018-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000089924318017931/0000899243-18-017931-index.htm
2018-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000089924318017932/0000899243-18-017932-index.htm
2018-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000089924318017933/0000899243-18-017933-index.htm
2018-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000089924318017937/0000899243-18-017937-index.htm
2018-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000089924318017939/0000899243-18-017939-index.htm
2018-12-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000089924318030853/0000899243-18-030853-index.htm
2018-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000089924318030857/0000899243-18-030857-index.htm
2019-03-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000089924319005423/0000899243-19-005423-index.htm
2019-03-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000089924319005424/0000899243-19-005424-index.htm
2019-03-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000089924319005425/0000899243-19-005425-index.htm
2019-03-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000089924319005426/0000899243-19-005426-index.htm
2019-03-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000089924319005427/0000899243-19-005427-index.htm
2019-03-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000089924319005428/0000899243-19-005428-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1559053/000090221919000055/0000902219-19-000055-index.htm
2020-01-28SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1559053/000090221920000282/0000902219-20-000282-index.htm
2019-08-05SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1559053/000093041319002242/0000930413-19-002242-index.htm
2019-01-31SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1559053/000093247119002258/0000932471-19-002258-index.htm
2019-08-26SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1559053/000093583619000452/0000935836-19-000452-index.htm
2019-12-13SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1559053/000093583619000657/0000935836-19-000657-index.htm
2019-03-28DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1559053/000114036119005885/0001140361-19-005885-index.htm
2019-03-28DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1559053/000114036119005887/0001140361-19-005887-index.htm
2020-03-12PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1559053/000114036120005628/0001140361-20-005628-index.htm
2020-03-25DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1559053/000114036120006746/0001140361-20-006746-index.htm
2020-03-25DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1559053/000114036120006747/0001140361-20-006747-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1559053/000117266120000654/0001172661-20-000654-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1559053/000117266120000847/0001172661-20-000847-index.htm
2018-08-1710-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1559053/000119312518251786/0001193125-18-251786-index.htm
2019-01-03CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1559053/000119312519001635/0001193125-19-001635-index.htm
2019-01-22CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1559053/000119312519014045/0001193125-19-014045-index.htm
2019-02-28CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1559053/000119312519058884/0001193125-19-058884-index.htm
2019-04-17CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1559053/000119312519108573/0001193125-19-108573-index.htm
2019-05-22S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1559053/000119312519154092/0001193125-19-154092-index.htm
2019-06-07CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1559053/000119312519168104/0001193125-19-168104-index.htm
2019-06-18CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1559053/000119312519175169/0001193125-19-175169-index.htm
2019-06-26CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1559053/000119312519181756/0001193125-19-181756-index.htm
2019-11-27S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1559053/000119312519302630/0001193125-19-302630-index.htm
2019-12-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1559053/000119312519310254/0001193125-19-310254-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1559053/000121390019002512/0001213900-19-002512-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1559053/000121390019002520/0001213900-19-002520-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1559053/000121390019002529/0001213900-19-002529-index.htm
2019-07-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1559053/000121390019012308/0001213900-19-012308-index.htm
2019-07-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1559053/000121390019012310/0001213900-19-012310-index.htm
2019-09-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1559053/000121390019017508/0001213900-19-017508-index.htm
2019-09-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1559053/000121390019017511/0001213900-19-017511-index.htm
2018-07-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1559053/000155905318000021/0001559053-18-000021-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1559053/000155905318000024/0001559053-18-000024-index.htm
2018-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1559053/000155905318000025/0001559053-18-000025-index.htm
2018-08-09S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1559053/000155905318000027/0001559053-18-000027-index.htm
2018-09-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1559053/000155905318000029/0001559053-18-000029-index.htm
2018-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1559053/000155905318000032/0001559053-18-000032-index.htm
2018-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1559053/000155905318000034/0001559053-18-000034-index.htm
2018-12-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1559053/000155905318000037/0001559053-18-000037-index.htm
2019-02-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1559053/000155905319000004/0001559053-19-000004-index.htm
2019-03-1510-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1559053/000155905319000007/0001559053-19-000007-index.htm
2019-04-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1559053/000155905319000009/0001559053-19-000009-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1559053/000155905319000012/0001559053-19-000012-index.htm
2019-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1559053/000155905319000013/0001559053-19-000013-index.htm
2019-05-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1559053/000155905319000016/0001559053-19-000016-index.htm
2019-07-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1559053/000155905319000018/0001559053-19-000018-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1559053/000155905319000022/0001559053-19-000022-index.htm
2019-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1559053/000155905319000023/0001559053-19-000023-index.htm
2019-09-208-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1559053/000155905319000026/0001559053-19-000026-index.htm
2019-09-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1559053/000155905319000028/0001559053-19-000028-index.htm
2019-10-308-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1559053/000155905319000031/0001559053-19-000031-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1559053/000155905319000034/0001559053-19-000034-index.htm
2019-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1559053/000155905319000035/0001559053-19-000035-index.htm
2019-12-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1559053/000155905319000037/0001559053-19-000037-index.htm
2019-12-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1559053/000155905319000040/0001559053-19-000040-index.htm
2020-02-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1559053/000155905320000003/0001559053-20-000003-index.htm
2020-03-0310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1559053/000155905320000005/0001559053-20-000005-index.htm
2020-04-24DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1559053/000155905320000007/0001559053-20-000007-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1559053/000155905320000012/0001559053-20-000012-index.htm
2020-05-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1559053/000155905320000013/0001559053-20-000013-index.htm
2020-05-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1559053/000155905320000015/0001559053-20-000015-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1559053/000155905320000024/0001559053-20-000024-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1559053/000155905320000026/0001559053-20-000026-index.htm
2020-08-11S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1559053/000155905320000029/0001559053-20-000029-index.htm
2020-10-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1559053/000155905320000033/0001559053-20-000033-index.htm
2020-11-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1559053/000155905320000038/0001559053-20-000038-index.htm
2020-11-0410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1559053/000155905320000040/0001559053-20-000040-index.htm
2019-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000156761919012070/0001567619-19-012070-index.htm
2019-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000156761919012071/0001567619-19-012071-index.htm
2019-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000156761919012072/0001567619-19-012072-index.htm
2019-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000156761919012073/0001567619-19-012073-index.htm
2019-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000156761919012075/0001567619-19-012075-index.htm
2019-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000156761919012077/0001567619-19-012077-index.htm
2019-07-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000156761919014386/0001567619-19-014386-index.htm
2019-07-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000156761919014387/0001567619-19-014387-index.htm
2019-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000156761919014388/0001567619-19-014388-index.htm
2019-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000156761919014389/0001567619-19-014389-index.htm
2019-08-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000156761919017610/0001567619-19-017610-index.htm
2019-12-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000156761919023078/0001567619-19-023078-index.htm
2020-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000156761920005017/0001567619-20-005017-index.htm
2020-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000156761920005018/0001567619-20-005018-index.htm
2020-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000156761920005019/0001567619-20-005019-index.htm
2020-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000156761920005020/0001567619-20-005020-index.htm
2020-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000156761920005021/0001567619-20-005021-index.htm
2020-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000156761920005022/0001567619-20-005022-index.htm
2020-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000156761920005023/0001567619-20-005023-index.htm
2020-03-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000156761920005645/0001567619-20-005645-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000156761920005646/0001567619-20-005646-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000156761920011030/0001567619-20-011030-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000156761920011031/0001567619-20-011031-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000156761920011034/0001567619-20-011034-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000156761920011035/0001567619-20-011035-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000156761920011037/0001567619-20-011037-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000156761920011039/0001567619-20-011039-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000156761920011041/0001567619-20-011041-index.htm
2020-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1559053/000156761920015757/0001567619-20-015757-index.htm
2019-12-12EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1559053/999999999519002790/9999999995-19-002790-index.htm
2018-08-22CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1559053/999999999718007410/9999999997-18-007410-index.htm
2019-03-28CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1559053/999999999719002098/9999999997-19-002098-index.htm
2019-07-12CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1559053/999999999719006122/9999999997-19-006122-index.htm

Prothena Corporation plc (PRTA) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Prothena Corporation plc (PRTA). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 5%
Institutional Ownership: 9470%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-08-17Gene G. KinneyPresident and CEOBuy10,000.006.4164,100.0012,793.00https://www.sec.gov/Archives/edgar/data/1559053/000156761920015757/0001567619-20-015757-index.htm